PR251424en

National Patient Safety Alert: Precautionary Class I Recall of Ozempic®

Batch Number - PP5N682::RN287 – Malta

The Marketing Authorisation Holder, Novo Nordisk® has alerted the Malta Medicines Authority that one (1) pack of Ozempic® 1mg solution for injection in pre-filled pen from batch number PP5N682::RN287 is suspected to be possibly falsified.

As a precautionary measure based on the report of Novo Nordisk®, a patient-level recall of Ozempic® 1mg solution for injection in pre-filled pen with the following batch number and expiry date is being carried out. This recall applies to this batch only.

Batch Number PP5N682::RN287

Expiry Date  02/2027

If you are in possession of Ozempic® 1mg solution for injection in pre-filled pen belonging to this batch (refer to attached photo):

i. Stop using the affected product

ii. Contact your pharmacy to verify the batch of the medicine

iii. Return the affected pack to the pharmacy from where the pack was purchased

iv. Speak to your pharmacist or medical practitioner to seek continuation of treatment

The Superintendent of Public Health as the Licencing Authority with the assistance of the Malta Medicines Authority are actively working with the relevant stakeholders to safeguard any possible risk to public health.

If you have any questions or concerns, speak to your pharmacist or medical practitioner for guidance.

Photos of the outer packaging of the batch of Ozempic® 1mg solution for injection in pre-filled pen being recalled.

For the Maltese version, kindly click here.